Sumanta K. Pal/X
Jan 26, 2025, 08:41
Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management
Sumanta K. Pal, Medical Oncologist at City of Hope, posted the following on X:
“Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management (local v systemic). As both concede, data for emerging local therapies very compelling, but possibly (possibly) a role for local + systemic.
Great paper from Roger in Nature Medicine that supports this approach.”
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
Authors: Roger Li et al.
Alexander R. A. Anderson
Carlos M Moran Segura
Colin P.N. Dinney
Denise Dorman
G. Daniel Grass
Gustavo Borjas
James J. Mulé
James M. Burke
Jasreman Dhillon
Jingsong Zhang
John J. Powers
Jose R. Conejo-Garcia
Joseph O. Johnson
Julio M. Pow-Sang
Logan Zemp
Michael A. Poch
Michiel van der Heijden
Nancy Y. Villa
Natasha Francis
Paulo C. Rodriguez
Philippe E. Spiess
Roger Li
Rohit K. Jain
Scott M. Gilbert
Tingyi Li
Wade J. Sexton
Xiaoqing Yu
Xuefeng Wang
Youngchul Kim
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 26, 2025, 08:17
Jan 26, 2025, 08:11
Jan 26, 2025, 07:45